General Information of the Compound
Compound ID |
CP0000212
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
()-2-(6-Chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane
Show/Hide
|
||||||||||||||||||
Synonyms |
(R)-2-(6-Chloro-pyridin-3-yl)-7-aza-bicyclo[221]heptane
140111-52-0
208/210 Epibatidine
AC1L1AYB
AC1Q3PYA
BSPBio_001263
CHEMBL6623
KBioGR_000603
KBioSS_000603
NLPRAJRHRHZCQQ-UHFFFAOYSA-N
SR-01000597620
[125I]EPIBATIDINE
[125I]epibatidine
[3H]EPIBATIDINE
[3H]epibatidine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C11H13ClN2
|
||||||||||||||||||
Molecular Weight |
208.692
|
||||||||||||||||||
Canonical SMILES |
Clc1ccc(cn1)C1CC2CCC1N2
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C11H13ClN2/c12-11-4-1-7(6-13-11)9-5-8-2-3-10(9)14-8/h1,4,6,8-10,14H,2-3,5H2
Show/Hide
|
||||||||||||||||||
InChIKey |
NLPRAJRHRHZCQQ-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03766, Acetylcholine receptor subunit alpha
Protein ID: PT06580, Neuronal acetylcholine receptor subunit alpha-2
Protein ID: PT02515, Neuronal acetylcholine receptor subunit alpha-3
Protein ID: PT07206, Neuronal acetylcholine receptor subunit alpha-4
Protein ID: PT01846, Neuronal acetylcholine receptor subunit alpha-7
Clinical Information about the Compound